XTX Topco Ltd Takes Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

XTX Topco Ltd bought a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 39,976 shares of the company's stock, valued at approximately $295,000.

Other hedge funds have also recently made changes to their positions in the company. Blue Trust Inc. raised its holdings in shares of LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after buying an additional 2,122 shares during the period. R Squared Ltd purchased a new position in LifeStance Health Group during the 4th quarter valued at $80,000. Cibc World Markets Corp purchased a new stake in shares of LifeStance Health Group in the 4th quarter worth $96,000. Handelsbanken Fonder AB purchased a new stake in shares of LifeStance Health Group in the 4th quarter worth $128,000. Finally, Versor Investments LP purchased a new stake in shares of LifeStance Health Group in the 4th quarter worth $131,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Stock Up 0.2 %

NASDAQ:LFST traded up $0.01 during mid-day trading on Wednesday, hitting $6.57. 752,868 shares of the company's stock traded hands, compared to its average volume of 1,618,219. The company has a fifty day moving average of $6.91 and a 200 day moving average of $7.30. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The company has a market capitalization of $2.55 billion, a P/E ratio of -25.27 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. KeyCorp initiated coverage on LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price for the company. Finally, Canaccord Genuity Group initiated coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price target for the company. One investment analyst has rated the stock with a sell rating, one has given a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $8.30.

Insider Activity at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares of the company's stock, valued at $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 6.60% of the stock is currently owned by corporate insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.